Neoplasm Recurrence, Local
"Neoplasm Recurrence, Local" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The local recurrence of a neoplasm following treatment. It arises from microscopic cells of the original neoplasm that have escaped therapeutic intervention and later become clinically visible at the original site.
| Descriptor ID |
D009364
|
| MeSH Number(s) |
C04.697.655 C23.550.727.655
|
| Concept/Terms |
Neoplasm Recurrence, Local- Neoplasm Recurrence, Local
- Local Neoplasm Recurrences
- Locoregional Neoplasm Recurrence
- Recurrences, Local Neoplasm
- Neoplasm Recurrences, Local
- Recurrence, Local Neoplasm
- Recurrence, Locoregional Neoplasm
- Local Neoplasm Recurrence
- Neoplasm Recurrence, Locoregional
- Locoregional Neoplasm Recurrences
- Neoplasm Recurrences, Locoregional
- Recurrences, Locoregional Neoplasm
|
Below are MeSH descriptors whose meaning is more general than "Neoplasm Recurrence, Local".
Below are MeSH descriptors whose meaning is more specific than "Neoplasm Recurrence, Local".
This graph shows the total number of publications written about "Neoplasm Recurrence, Local" by people in this website by year, and whether "Neoplasm Recurrence, Local" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 7 | 9 | 16 |
| 1997 | 4 | 8 | 12 |
| 1998 | 0 | 7 | 7 |
| 1999 | 6 | 4 | 10 |
| 2000 | 5 | 13 | 18 |
| 2001 | 3 | 10 | 13 |
| 2002 | 4 | 4 | 8 |
| 2003 | 9 | 10 | 19 |
| 2004 | 10 | 11 | 21 |
| 2005 | 7 | 14 | 21 |
| 2006 | 18 | 12 | 30 |
| 2007 | 13 | 15 | 28 |
| 2008 | 8 | 16 | 24 |
| 2009 | 14 | 12 | 26 |
| 2010 | 19 | 19 | 38 |
| 2011 | 14 | 7 | 21 |
| 2012 | 16 | 12 | 28 |
| 2013 | 20 | 20 | 40 |
| 2014 | 17 | 17 | 34 |
| 2015 | 26 | 17 | 43 |
| 2016 | 27 | 15 | 42 |
| 2017 | 24 | 8 | 32 |
| 2018 | 20 | 22 | 42 |
| 2019 | 31 | 25 | 56 |
| 2020 | 23 | 32 | 55 |
| 2021 | 24 | 27 | 51 |
| 2022 | 7 | 42 | 49 |
| 2023 | 2 | 43 | 45 |
| 2024 | 16 | 25 | 41 |
| 2025 | 19 | 10 | 29 |
| 2026 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Neoplasm Recurrence, Local" by people in Profiles.
-
Machine Learning-Based Prediction of Distant Recurrence Risk and Ribociclib Treatment Effect in HR+/HER2- Early Breast Cancer Using Real-World and NATALEE Data. Clin Cancer Res. 2026 Jan 16; 32(2):428-437.
-
Adjuvant Chemotherapy Use for Hormone Receptor-Positive, ERBB2-Negative Breast Cancer After RxPONDER Trial. JAMA Netw Open. 2025 Dec 01; 8(12):e2549109.
-
Impact of anthracyclines in genomic high-risk, node-negative, HR-positive/HER2-negative breast cancer. Ann Oncol. 2025 Nov; 36(11):1356-1365.
-
Efficacy and safety of one-time autologous tumor-infiltrating lymphocyte cell therapy in patients with recurrent and/or metastatic head and neck squamous cell carcinoma. J Immunother Cancer. 2025 Aug 24; 13(8).
-
Outcomes of relapsed/refractory peripheral T-cell lymphoma in the modern era: impact of stem cell transplant and novel agents. Leuk Lymphoma. 2025 Dec; 66(13):2437-2447.
-
Early Dynamics of Circulating Tumor HPV-DNA with Neoadjuvant Chemotherapy and Response-Adapted De-escalation in Human Papillomavirus-Associated Oropharyngeal Cancer. Clin Cancer Res. 2025 Aug 01; 31(15):3150-3159.
-
High-fat diet driven post-operative colon cancer recurrence is dependent upon genetic susceptibility to deoxycholic acid. Cancer Lett. 2025 Oct 28; 631:217943.
-
Feasibility of Personalized and Tumor-Informed Circulating Tumor DNA Assay for Early Recurrence Detection in Patients With Hepatocellular Carcinoma. JCO Precis Oncol. 2025 Jul; 9:e2400934.
-
Tumor-intrinsic and immune-related features associated with treatment failure in human papillomavirus-related oropharyngeal cancer. J Natl Cancer Inst. 2025 Jul 01; 117(7):1366-1376.
-
The Evolving Management of Radiorecurrent Prostate Cancer. Semin Radiat Oncol. 2025 Jul; 35(3):450-462.